findmyKOL

Lisa Wilsbacher, MD, PhD

Basic profile

Northwestern University

ORCID↗NPI↗
✓ Full record
RegionChicago, IL · MidwestSpecialtyCardiovascular DiseaseFocusCardiology
Active KOLfindmyKOL type: RegionalLatest publication2026Online presenceNot yet checkedPayments2021 onwardNIH funding2015–2015

Lisa Wilsbacher is a Cardiology physician affiliated with Northwestern University. OpenAlex indexes 82 publications with 7,918 citations (h-index 21).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
82publications

Distinct works indexed by OpenAlex, matched via ORCID.

7,918citations

Total citations across indexed works.

21h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
3companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
1NIH grants · 2015–2015

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

675 N Saint Clair St
Galter Suite 19-100
Chicago, IL 606115975

Telephone

312-664-3278

Registry record last updated 16 Mar 2015.

View the NPPES registry record

Industry payments

3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    87.2%
    Beta blocker24.4%
    Metoprolol Succinate70%Carvedilol21%Metoprolol Tartrate9%
    Part D<11 patients
    Statin20.8%
    Atorvastatin Calcium61%Rosuvastatin Calcium39%
    Part D≥42 patients

    + 11 more classes in this area

  • Blood & clotting

    10.5%
    Factor Xa inhibitor7.5%
    Eliquis86%Xarelto14%
    Part D<11 patients
    P2Y12 inhibitor3%
    Clopidogrel100%
    Part D<11 patients
  • Metabolism & gastrointestinal

    2.4%
    SGLT2 inhibitor2.4%
    Jardiance100%
    Part D≥11 patients
Where care is delivered (Part B)30.1% facility · 69.9% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

1 NIH research award on record, funded 2015–2015 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”